ANTHIM
ANTHIM
Restricted Access
DIN Number
02502895
Drug Class
Human
Market Date
N/A
Company
HC
Elusys Therapeutics, Inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02502895
AIG Number0162416001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
J06BC04 OBILTOXAXIMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification80:04.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
OBILTOXAXIMABActive
Strength: 100 MG / ML
Monograph: OBILTOXAXIMAB